Page last updated: 2024-12-11

achatin i

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

achatin I: neuroexcitatory tetrapeptide from Achatina fulica Ferussac (African giant snail); achatin-I has D-Phe residue; achatin-II has L-Phe [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID5486682
MeSH IDM0166581

Synonyms (14)

Synonym
achatin i
(2s)-2-[[(2s)-2-[[(2r)-2-[(2-aminoacetyl)amino]-3-phenylpropanoyl]amino]propanoyl]amino]butanedioic acid
121912-19-4
achatin-ii
gfad peptide
l-aspartic acid, n-(n-(n-glycyl-d-phenylalanyl)-l-alanyl)-
gly-phe-ala-asp
gly-delta(z)-phe(2)-ala-asp
achatin-i
glycyl-phenylalanyl-alanyl-aspartic acid
n-[2-({2-[(2-amino-1-hydroxyethylidene)amino]-1-hydroxy-3-phenylpropylidene}amino)-1-hydroxypropylidene]aspartic acid
DTXSID60924016
glycyl-d-phenylalanyl-l-alanyl-l-aspartic acid
AKOS040750099

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" achatin-I (I) were calculated from their dose-response curves: 8 - 60 for Gly-Gly-DPhe-L-Ala-L-Asp (IV), 200 - greater than 250 for D-Phe-L-Ala-L-Asp (V) and greater than 200 for Gly-D-Phe-L-Ala-L-Asn (XVI)."( Structure-activity relationship studies on the endogenous neuroactive tetrapeptide achatin-I on giant neurons of Achatina fulica Ferussac.
Kamatani, Y; Kim, KH; Minakata, H; Nomoto, K; Takeuchi, H, 1991
)
0.28
" Dose-response curves of achatin-I and [D-Ala3]-achatin-I for producing the inward current of PON were measured under voltage clamp at a holding membrane voltage (Vh) of -50 mV."( Isolation of achatin-I, a neuroactive tetrapeptide having a D-phenylalanine residue, from Achatina ganglia, and its effects on Achatina giant neurones.
Kamatani, Y; Kim, KH; Minakata, H; Nomoto, K; Takeuchi, H; Yongsiri, A, 1991
)
0.28
" The dose-response curves of FMRFamide, APGW-amide and oxytocin, indicated that their respective suppressive effects on the Iin of achatin-I were dose-dependent, and that APGW-amide was slightly more potent than the other peptides."( Suppressing effects of neuroactive peptides on the inward current caused by achatin-I, an Achatina endogenous peptide.
Liu, GJ; Takeuchi, H, 1995
)
0.29
" The dose-response curves of the effective histamine H1 antagonists indicated their potency order to suppress the Iin as follows: chlorcyclizine, promethazine, triprolidine and homochlorcyclizine > trimeprazine and clemastine > diphenylpyraline."( Blockers for excitatory effects of achatin-I, a tetrapeptide having a D-phenylalanine residue, on a snail neurone.
Liu, GJ; Santos, DE; Takeuchi, H, 1995
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (30)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (3.33)18.7374
1990's24 (80.00)18.2507
2000's3 (10.00)29.6817
2010's2 (6.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.61

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.61 (24.57)
Research Supply Index3.43 (2.92)
Research Growth Index6.05 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.61)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other28 (93.33%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]